Progress towards therapies for disease modification in Parkinson's disease
N Vijiaratnam, T Simuni, O Bandmann… - The Lancet …, 2021 - thelancet.com
The development of interventions to slow or halt the progression of Parkinson's disease
remains a priority for patients and researchers alike. To date, no agents have been shown to …
remains a priority for patients and researchers alike. To date, no agents have been shown to …
Progress towards therapies for disease modification in Parkinson's disease.
N Vijiaratnam, T Simuni, O Bandmann… - The Lancet …, 2021 - europepmc.org
The development of interventions to slow or halt the progression of Parkinson's disease
remains a priority for patients and researchers alike. To date, no agents have been shown to …
remains a priority for patients and researchers alike. To date, no agents have been shown to …
Progress towards therapies for disease modification in Parkinson's disease
N Vijiaratnam, T Simuni, O Bandmann… - The Lancet …, 2021 - scholars.northwestern.edu
The development of interventions to slow or halt the progression of Parkinson's disease
remains a priority for patients and researchers alike. To date, no agents have been shown to …
remains a priority for patients and researchers alike. To date, no agents have been shown to …
Progress towards therapies for disease modification in Parkinson's disease
N Vijiaratnam, T Simuni, O Bandmann… - The Lancet …, 2021 - pubmed.ncbi.nlm.nih.gov
The development of interventions to slow or halt the progression of Parkinson's disease
remains a priority for patients and researchers alike. To date, no agents have been shown to …
remains a priority for patients and researchers alike. To date, no agents have been shown to …
[引用][C] Progress towards therapies for disease modification in Parkinson's disease
N Vijiaratnam, T Simuni, O Bandmann, HR Morris… - The Lancet …, 2021 - cir.nii.ac.jp
Progress towards therapies for disease modification in Parkinson's disease | CiNii Research
CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データを …
CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データを …
[PDF][PDF] Progress towards therapies for disease modification in Parkinson's disease
N Vijiaratnam, MD Tanya Simuni, O Bandmann… - core.ac.uk
The development of interventions to slow or halt the progression of Parkinson's disease (PD)
remains the major priority for people affected with the illness and PD researchers alike. To …
remains the major priority for people affected with the illness and PD researchers alike. To …
Progress towards therapies for disease modification in Parkinson's disease
N Vijiaratnam, T Simuni, O Bandmann, HR Morris… - The Lancet …, 2021 - Elsevier
The development of interventions to slow or halt the progression of Parkinson's disease
remains a priority for patients and researchers alike. To date, no agents have been shown to …
remains a priority for patients and researchers alike. To date, no agents have been shown to …
Progress towards therapies for disease modification in Parkinson's disease
N Vijiaratnam, T Simuni, O Bandmann… - The Lancet …, 2021 - discovery.ucl.ac.uk
The development of interventions to slow or halt the progression of Parkinson's disease
remains a priority for patients and researchers alike. To date, no agents have been shown to …
remains a priority for patients and researchers alike. To date, no agents have been shown to …